Matthew Kent is co-leader of Alston & Bird’s Antitrust Team and a partner in the firm’s Litigation & Trial Practice Group who specializes in bet-the-company antitrust litigation and counselling. Matthew and his team have recovered nearly $1 billion in settlements for clients.
Matthew has defended Fortune 100 companies alleged to have participated in global price-fixing cartels in DOJ criminal investigations and follow-on civil litigation. He has a deep experience with the competition issues at the forefront of the pharmaceutical industry and has litigated cases in federal courts throughout the country.
He advises clients on antitrust issues related to joint ventures and mergers and acquisitions, including filings under the HSR Act and international premerger notification regimes. Matthew assists clients with substantive merger reviews by the U.S. Department of Justice, the Federal Trade Commission, and foreign competition authorities in a host of industries.
Matthew has been recognized for his antitrust acumen by Georgia Super Lawyers, Who’s Who Legal, and Chambers USA. Clients say he is their “go-to lawyer for creative and practical solutions to the most complex legal issues.” For over a decade, he has been active in the leadership of the American Bar Association’s Antitrust Law Section, serving three-year terms as co-chair of the Unilateral Conduct Committee and the Business Torts and Civil RICO Committee. He was recently appointed to the Antitrust Section’s Reserve Task Force.